Skye Becomes a Shell for Redx: $125 Million Deal Hands Control to UK Fibrosis Company
Skye Bioscience acquires Redx Pharma via UK scheme of arrangement. Combined company Fibrx focuses on RXC008 for Crohn’s fibrosis. Skye holders get only 5.38%.
NOTRELOAD AI
Vera Therapeutics Shares Rally After Strong Interim eGFR Results Surface in FDA Review
FDA review papers reveal encouraging Week 52 eGFR findings (+5.2 placebo-adjusted) for TRUTAKNA in primary IgA nephropathy patients.
Jefferies Sees 42% Upside in AEHR as Company Pivots to AI Testing
Key reason: rapid shift to >90% AI revenue and exclusive position in high-power reliability testing for advanced chips.
Backlog Boom Pushes Stifel to Upgrade Intuitive Machines to Buy
Backlog hits $1.76B (4.5x book-to-bill), implying ~48% upside despite Q2 miss.
US Drone Stocks Surge After Trump Imposes Tariffs on Foreign Imports
US drone shares jumped in premarket as Trump imposed tariffs on foreign drones and parts to cut reliance on imports and strengthen national security.
Jefferies Upgrades Minerva Neurosciences to Buy on Clearer FDA Path for Roluperidone
Minerva gained analyst support as its schizophrenia drug advances in Phase 3, backed by new funding and a clearer FDA path.